Netflix’s Sean Krankel talks about developing a mobile game directly with Black Mirror creator Charlie Brooker ...

A distant galaxy that lay quiet for decades has suddenly stirred, lighting up in dramatic bursts that have caught astronomers ...

Astronomers are investigating the longest and most energetic bursts of X-rays seen from a newly awakened black hole. Watching this strange behavior unfold in real time offers a unique opportunity to ...

"This rare event provides an opportunity for astronomers to observe a black hole's behavior in real time," said astronomer Lorena Hernández-García.

There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study suggests. The research team, led by Michigan Medicine ...

I really didn’t.” It turns out the then 53-year-old was having a widowmaker heart attack. “His color had turned gray, and he was sweating profusely, and he was doing that coughing, ...

MINNEAPOLIS — People who have early signs of heart problems may also have changes in brain health that can be early signs of dementia, such as loss of brain volume, according to a meta-analysis ...

Get Instant Summarized Text (Gist) Early signs of heart problems, such as systolic and diastolic dysfunction, are associated with smaller brain volumes, potentially indicating early dementia. This ...

POLK COUNTY, North Carolina (WLOS) — The N.C. Forest Service provided the following update Tuesday on the Black Cove Complex fire in Polk County: Black Cove Fire: 3,046 Acres, 0% Contained Deep ...

The White House announced Tuesday it came to an agreement with Ukraine and Russia to “eliminate the use of force” in the Black Sea, as well as end strikes on energy facilities, marking one of ...

And now, a new risk for anyone who has ever tested positive. “What was surprising to find is just having a COVID-19-positive test was associated with a twofold increased risk in heart attack, stroke, ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, the US drugmaker’s second recent foray into China for a novel medicine.